(Q37866813)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504398%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

review article

1 reference

title

Immunological risk factors for infection after immunosuppressive and biologic therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504398%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504398%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Elizabeth Sarmiento

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504398%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Nadia del Pozo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504398%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Antonio Gallego

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504398%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504398%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504398%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504398%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504398%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

405-413

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504398%20AND%20SRC:MED&resulttype=core&format=json

Infection in organ transplantation: risk factors and evolving patterns of infection

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Immune monitoring to predict the development of infections after immunosuppression for solid organ transplantation and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

The EUROclass trial: defining subgroups in common variable immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

From research tool to routine test: CD38 monitoring in HIV patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

The risk of infections with biologic therapies for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non-Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin's lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Does rituximab aggravate pre-existing hypogammaglobulinaemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

IgG monitoring to identify the risk for development of infection in heart transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Hypogammaglobulinemia in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Hypogammaglobulinemia: Incidence, risk factors, and outcomes following pediatric lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Fungi and molds following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Linking CMV serostatus to episodes of CMV reactivation following lung transplantation by measuring CMV-specific CD8+ T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Activated virus-specific T cells are early indicators of anti-CMV immune reactions in liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Recovery of functional memory T cells in lung transplant recipients following induction therapy with alemtuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Narrowing of T-cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Chlamydia pneumoniae-induced memory CD4+ T-cell activation in human peripheral blood correlates with distinct antibody response patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Adoptive T-cell therapy of a lung transplanted patient with severe CMV disease and resistance to antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Changing trends in infectious disease in heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

T cell homeostasis in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

The Influence of Innate Immunity Gene Receptors Polymorphisms in Renal Transplant Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: An open-label extension analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Decreased Levels of Serum Immunoglobulins as a Risk Factor for Infection After Heart Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Clostridium difficile–associated Diarrhea in Heart Transplant Recipients: Is Hypogammaglobulinemia the Answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

The Potential Impact of Substitutive Therapy With Intravenous Immunoglobulin on the Outcome of Heart Transplant Recipients With Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Association Between Mannose-Binding Lectin Deficiency and Cytomegalovirus Infection After Kidney Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.178

21 January 2018

Identifiers

DOI

10.1586/ERI.10.178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504398%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference